LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

CAPITAL PERFORMANCE ADVISORS LLP's Holding History (CIK: 0001905663)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 163 Value ($000) $0 Avg Close $0.93 Range $0.77 - $1.15